Is AVNE or MRK a better dividend investment in 2026?

AVNE currently yields 5000000.00% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: AVNE offers higher current income.

What is the dividend yield difference between AVNE and MRK?

AVNE has a forward dividend yield of 5000000.00% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 4999997.24 percentage points.

Home › Compare › AVNE vs MRK

AVNE vs MRK: Dividend Comparison 2026

AVNE yields 5000000.00% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 AVNE wins by $4.651129742658086e+43M in total portfolio value

INVESTMENT

TIME HORIZON10 years

AVNE

● Live price

5000000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4.651129742658086e+43M

Annual income

$46,509,467,603,334,410,000,000,000,000,000,000,000,000,000,000,000.00

Full AVNE calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — AVNE vs MRK

📍 AVNE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	AVNE	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, AVNE + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

AVNE pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AVNE

Annual income on $10K today (after 15% tax)

$425,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$39,533,047,462,834,250,000,000,000,000,000,000,000,000,000,000,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, AVNE beats the other by $39,533,047,462,834,250,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AVNE + MRK for your $10,000?

AVNE: 50%MRK: 50%

100% MRK50/50100% AVNE

Portfolio after 10yr

$2.325564871329043e+43M

Annual income

$23,254,733,801,667,206,000,000,000,000,000,000,000,000,000,000,000.00/yr

Blended yield

100.00%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

AVNE

No analyst data

Altman Z

-4892.6

Piotroski

2/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AVNE buys

MRK buys

No recent congressional trades found for AVNE or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAVNEMRK

Forward yield	5000000.00% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$4.651129742658086e+43M	$56.8K ✓
Annual income after 10y	$46,509,467,603,334,410,000,000,000,000,000,000,000,000,000,000,000.00 ✓	$9,798.13
Total dividends collected	$4.651117771440442e+43M	$28.9K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: AVNE vs MRK ($10,000, DRIP)

Year	AVNE Portfolio	AVNE Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$500,010,700	$500,000,000.00	$11,206	$366.19	+$500.00M → AVNE
2	$23,365,520,992,757	$23,364,985,981,308.41	$12,650	$502.35	+$23365520.98M → AVNE
3	$1,020,442,548,175,215,100	$1,020,417,547,067,752,800.00	$14,407	$694.19	+$1020442548175.20M → AVNE
4	$41,650,346,151,752,480,000,000	$41,649,254,278,225,940,000,000.00	$16,585	$967.82	+$41650346151752480.00M → AVNE
5	$1,588,787,048,835,084,000,000,000,000	$1,588,742,482,964,701,800,000,000,000.00	$19,342	$1,363.89	+$1.588787048835084e+21M → AVNE
6	$56,640,860,400,245,200,000,000,000,000,000	$56,639,160,398,102,940,000,000,000,000,000.00	$22,913	$1,947.19	+$5.66408604002452e+25M → AVNE
7	$1,887,170,449,619,629,000,000,000,000,000,000,000	$1,887,109,843,899,000,500,000,000,000,000,000,000.00	$27,662	$2,823.89	+$1.887170449619629e+30M → AVNE
8	$58,763,764,792,023,670,000,000,000,000,000,000,000,000	$58,761,745,519,642,570,000,000,000,000,000,000,000,000.00	$34,159	$4,173.35	+$5.876376479202367e+34M → AVNE
9	$1,710,115,183,602,138,000,000,000,000,000,000,000,000,000,000	$1,710,052,306,373,811,000,000,000,000,000,000,000,000,000,000.00	$43,337	$6,308.80	+$1.710115183602138e+39M → AVNE
10	$46,511,297,426,580,864,000,000,000,000,000,000,000,000,000,000,000	$46,509,467,603,334,410,000,000,000,000,000,000,000,000,000,000,000.00	$56,776	$9,798.13	+$4.651129742658086e+43M → AVNE

AVNE vs MRK: Complete Analysis 2026

AVNE — Stock

Aventura Equities, Inc., through its subsidiary, engages in the alternative fuels industry. It produces algae to utilize it as a fuel and food source; develops gasification projects for the commercial production of energy in the United States; produces syn-gas and methane for power generation; and operates refinery operations for the production of transportation fuels. The company was formerly known as Winsted Holdings, Inc. and changed its name to Aventura Equities, Inc. in October 2008. Aventura Equities, Inc. was incorporated in 1997 and is based in Georgetown, South Carolina.

Full AVNE Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this AVNE vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AVNE vs SCHD AVNE vs JEPI AVNE vs O AVNE vs KO AVNE vs MAIN AVNE vs JNJ AVNE vs ABBV AVNE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.